Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol with Plasma Exchange and Steroids for TTP
NCT00953771Phase 2Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2008
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of danazol in thrombotic thrombocytopenic purpura (TTP), sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2008; status: terminated.
02
Drugs
danazol
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT00953771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953771.